PolyPeptide Group AG engages in the business of development, manufacturing, and marketing of peptide- and oligonucleotide-based compounds for use in the pharmaceutical and related research industries. The company is headquartered in Baar, Zug and currently employs 1,366 full-time employees. The company went IPO on 2021-04-29.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue
391
391
338
324
283
286
Revenue Growth (YoY)
16%
16%
4%
14%
-1%
28%
Cost of Revenue
325
324
299
315
228
182
Gross Profit
66
67
39
9
54
103
Selling, General & Admin
55
54
42
39
39
36
Research & Development
2
2
1
1
1
1
Operating Expenses
57
57
45
43
41
39
Other Non Operating Income (Expenses)
--
-1
-3
-1
-1
0
Pretax Income
-20
-20
-18
-58
7
59
Income Tax Expense
1
1
1
-6
0
12
Net Income
-21
-21
-19
-51
7
47
Net Income Growth
11%
11%
-63%
-828.99%
-85%
52%
Shares Outstanding (Diluted)
33.07
33.12
33.12
33.12
33.12
32.12
Shares Change (YoY)
-2%
0%
0%
0%
3%
-3%
EPS (Diluted)
-0.63
-0.63
-0.59
-1.55
0.23
1.47
EPS Growth
8%
8%
-62%
-762%
-84%
56%
Free Cash Flow
-31
-31
2
-20
-73
-20
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
16.87%
17.13%
11.53%
2.77%
19.08%
36.01%
Operating Margin
2.04%
2.3%
-1.47%
-10.18%
4.24%
22.37%
Profit Margin
-5.37%
-5.37%
-5.62%
-15.74%
2.47%
16.43%
Free Cash Flow Margin
-7.92%
-7.92%
0.59%
-6.17%
-25.79%
-6.99%
EBITDA
46
47
27
-3
38
84
EBITDA Margin
11.76%
12.02%
7.98%
-0.92%
13.42%
29.37%
D&A For EBITDA
38
38
32
30
26
20
EBIT
8
9
-5
-33
12
64
EBIT Margin
2.04%
2.3%
-1.47%
-10.18%
4.24%
22.37%
Effective Tax Rate
-5%
-5%
-5.55%
10.34%
0%
20.33%
Follow-Up Questions
What are PolyPeptide Group AG's key financial statements?
According to the latest financial statement (Form-10K), PolyPeptide Group AG has a total asset of $825, Net loss of $-21
What are the key financial ratios for PLYGF?
PolyPeptide Group AG's Current ratio is 1.7, has a Net margin is -5.37, sales per share of $11.8.
How is PolyPeptide Group AG's revenue broken down by segment or geography?
PolyPeptide Group AG largest revenue segment is Custom Projects, at a revenue of 150,058,267 in the most earnings release.For geography, Europe and Asia is the primary market for PolyPeptide Group AG, at a revenue of 221,135,636.
Is PolyPeptide Group AG profitable?
no, according to the latest financial statements, PolyPeptide Group AG has a net loss of $-21
Does PolyPeptide Group AG have any liabilities?
yes, PolyPeptide Group AG has liability of 485
How many outstanding shares for PolyPeptide Group AG?
PolyPeptide Group AG has a total outstanding shares of 33